Latest Updates
-
Horoscope for Today April 05, 2026 - Small Choices Guide Calm Momentum -
Happy Easter 2026 Wishes: Top 50+ Messages, Status, Captions And Posts To Share With Family And Friends -
Comfort Style Creamy Blend Tomato Soup Recipe -
Rashmika Mandanna’s “Now It’s Us Three” Post Sparks Speculation Ahead of Anime Awards 2026 Return -
The Softest Ever Homemade Gulab Jamun Recipe -
Where To Eat This Easter 2026: From Chef-Led Experiences To Traditional Feasts Across India -
International Carrot Day 2026: The Hydrating, Skin-Loving Vegetable To Eat More This Summer -
Fluffy Jeera Rice Every Time: The Simple Trick You Need To Know -
Parveen Babi 72nd Birth Anniversary: When A Modern, Unapologetic Style Icon Took Over Bollywood -
5.8 Magnitude Earthquake In Afghanistan Sends Tremors To Delhi: Why Deep Quakes Travel Across Borders
Brain Imaging
Washington : In a move to develop a more personalised approach towards medication depending upon genetic information or other biological markers, researchers have shed light on the potential use of functional magnetic resonance imaging (fMRI) to match treatments for patients with generalized anxiety disorder (GAD).
“Personalized medicine" is required as individuals in different groups respond to medications differently not only from individuals of other groups but those of the same group as well.
The researchers led by Dr. Paul Whalen examined subjects diagnosed with GAD who underwent brain scans both before and after treatment with venlafaxine, an antidepressant that has been shown to be effective in treating anxiety. They later measured the participants" responses to viewing pictures of fearful facial expressions during the fMRI scans.
“We focused our study on a regulatory circuit in the brain involving the amygdala, an area that serves to detect the presence of threatening information, and the prefrontal cortex, an area that functions to control these threat responses when they are exaggerated or unnecessary," said Whalen.
The results indicated that almost two thirds of the patients found relief from their anxiety symptoms after treatment, and amongst those who improved, some responded better than others. And according to the hypothesis, the fMRI data predicted who would do well on the drug and who would not.
Whalen said: “subjects who showed high prefrontal cortex activation together with low amygdala activation in response to the fearful faces reported a significant decrease in their anxiety symptoms, while those showing the reverse brain activation pattern (i.e., high amygdala, low prefrontal) did not."
The study was published in Biological Psychiatry.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications











